Neuronal cyclin-dependent kinase 5: Role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1697, Issue 1-2, 2004, Pages 143-153

  Kesavapany, Sashi ^a   Li, Bing Sheng ^a   Amin, Niranjana ^a   Zheng, Ya Li ^a   Grant, Philip ^a   Pant, Harish C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Alzheimer's disease; Cdk5; CIP; Cyclin dependent kinase 5; ERK1 2; Extracellular signal regulated kinase 1 2; Knock out; KO; KSP; Lysine serine proline; MAPK; Mitogen activated protein kinase; Neurofilament; NF; p35; Phosphorylation; Signal transduction; Tau

Indexed keywords

AMPHIPHYSIN; CALPAIN; CHOLINERGIC RECEPTOR; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; DYNAMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN P25; PROTEIN P35; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; VERY LATE ACTIVATION ANTIGEN 1;

APOPTOSIS; CONFERENCE PAPER; CYTOSKELETON; DEGENERATIVE DISEASE; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXOCYTOSIS; HUMAN; INHIBITION KINETICS; LABORATORY; NERVE CELL; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NEUROFILAMENT; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; STRUCTURE ANALYSIS; SYMPTOM; SYNAPSE;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVOUS SYSTEM PHYSIOLOGY; NEURODEGENERATIVE DISEASES; NEUROFILAMENT PROTEINS; NEURONS; PEPTIDES; SUBSTRATE SPECIFICITY; TAU PROTEINS;

EID: 1542269015     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2003.11.020     Document Type: Conference Paper

References (120)

1. Cobb M.H., Robbins D.J., Boulton T.G. ERKs, extracellular signal-regulated MAP-2 kinases. Curr. Opin. Cell Biol. 3:1991;1025-1032.
2. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:1991;663-675.
3. Simic G., Diana A., Hof P.R. Phosphorylation pattern of tau associated with distinct changes of the growth cone cytoskeleton. Prog. Mol. Subcell. Biol. 32:2003;33-48.
4. Michaelis M.L., Dobrowsky R.T., Li G. Tau neurofibrillary pathology and microtubule stability. J. Mol. Neurosci. 19:2002;289-293.
5. Veeranna, Shetty K.T., Link W.T., Jaffe H., Wang J., Pant H.C. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64:1995;2681-2690.
6. Julien J.P., Mushynski W.E. Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem. 257:1982;10467-10470.
7. Sternberger L.A., Sternberger N.H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. U. S. A. 80:1983;6126-6130.
8. Nixon R.A. The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiology. Brain Pathol. 3:1993;29-38.
9. Nixon R.A., Paskevich P.A., Sihag R.K., Thayer C.Y. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J. Cell Biol. 126:1994;1031-1046.
10. Sun D., Leung C.L., Liem R.K. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J. Biol. Chem. 271:1996;14245-14251.
11. Pant A.C., Veeranna, Pant H.C., Amin N. Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5). Brain Res. 765:1997;259-266.
12. Jaffe H., Veeranna, Shetty K.T., Pant H.C. Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. Biochemistry. 37:1998;3931-3940.
13. Jaffe H., Veeranna, Pant H.C. Characterization of serine and threonine phosphorylation sites in beta-elimination/ethanethiol addition-modified proteins by electrospray tandem mass spectrometry and database searching. Biochemistry. 37:1998;16211-16224.
14. Nguyen M.D., Lariviere R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron. 30:2001;135-147.
15. Shetty K.T., Link W.T., Pant H.C. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6844-6848.
16. Hisanaga S., Uchiyama M., Hosoi T., Yamada K., Honma N., Ishiguro K., Uchida T., Dahl D., Ohsumi K., Kishimoto T. Porcine brain neurofilament-H tail domain kinase: its identification as cdk5/p26 complex and comparison with cdc2/cyclin B kinase. Cell Motil. Cytoskelet. 31:1995;283-297.
17. Guidato S., McLoughlin D.M., Grierson A.J., Miller C.C. Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. J. Neurochem. 70:1998;335-340.
18. Xiong Y., Zhang H., Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505-514.
19. Miyajima M., Nornes H.O., Neuman T. Cyclin E is expressed in neurons and forms complexes with cdk5. NeuroReport. 6:1995;1130-1132.
20. Ishiguro K., Kobayashi S., Omori A., Takamatsu M., Yonekura S., Anzai K., Imahori K., Uchida T. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett. 342:1994;203-208.
21. Lew J., Huang Q.Q., Qi Z., Winkfein R.J., Aebersold R., Hunt T., Wang J.H. A brain-specific activator of cyclin-dependent kinase 5. Nature. 371:1994;423-426.
22. Tsai L.H., Delalle I., Caviness V.S. Jr., Chae T., Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 371:1994;419-423.
23. Humbert S., Dhavan R., Tsai L. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J. Cell. Sci. 113(Pt 6):2000;975-983.
24. Humbert S., Lanier L.M., Tsai L.H. Synaptic localization of p39, a neuronal activator of cdk5. NeuroReport. 11:2000;2213-2216.
25. Ma E., Haddad G. A Drosophila CDK5alpha-like molecule and its possible role in response to O(2) deprivation. Biochem. Biophys. Res. Commun. 261:1999;459-463.
26. Ino H., Ishizuka T., Chiba T., Tatibana M. Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in the mature and developing mouse central and peripheral nervous systems. Brain Res. 661:1994;196-206.
27. Hellmich M.R., Pant H.C., Wada E., Battey J.F. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10867-10871.
28. Gervasi C., Szaro B.G. The Xenopus laevis homologue to the neuronal cyclin-dependent kinase (cdk5) is expressed in embryos by gastrulation. Brain Res. Mol. Brain Res. 33:1995;192-200.
29. Toh E.A., Nishizawa M. Structure and function of cyclin-dependent Pho85 kinase of Saccharomyces cerevisiae. J. Gen. Appl. Microbiol. 47:2001;107-117.
30. Ohshima T., Kozak C.A., Nagle J.W., Pant H.C., Brady R.O., Kulkarni A.B. Molecular cloning and chromosomal mapping of the mouse gene encoding cyclin-dependent kinase 5 regulatory subunit p35. Genomics. 35:1996;372-375.
31. Ohshima T., Ward J.M., Huh C.G., Longenecker G., Veeranna, Pant H.C., Brady R.O., Martin L.J., Kulkarni A.B. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11173-11178.
32. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., Tsai L.H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10:1996;816-825.
33. Tanaka T., Veeranna, Ohshima T., Rajan P., Amin N.D., Cho A., Sreenath T., Pant H.C., Brady R.O., Kulkarni A.B. Neuronal cyclin-dependent kinase 5 activity is critical for survival. J. Neurosci. 21:2001;550-558.
34. Ko J., Humbert S., Bronson R.T., Takahashi S., Kulkarni A.B., Li E., Tsai L.H. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21:2001;6758-6771.
35. Xu Z., Dong D.L., Cleveland D.W. Neuronal intermediate filaments: new progress on an old subject. Curr. Opin. Neurobiol. 4:1994;655-661.
36. Lee M.K., Cleveland D.W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19:1996;187-217.
37. Jaffe H., Sharma P., Grant P., Pant H. Characterization of the phosphorylation sites of the squid (Loligo pealei) high-molecular-weight neurofilament protein from giant axon axoplasm. J. Neurochem. 76:2001;1022-1031.
38. Bajaj N.P., al-Sarraj S.T., Leigh P.N., Anderson V., Miller C.C. Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 23:1999;833-850.
39. Brownlees J., Yates A., Bajaj N.P., Davis D., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J. Cell. Sci. 113(Pt 3):2000;401-407.
40. Giasson B.I., Mushynski W.E. Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit. J. Neurosci. 17:1997;9466-9472.
41. Giasson B.I., Mushynski W.E. Okadaic acid reversibly inhibits neurite outgrowth in embryonic dorsal root ganglion neurons. J. Neurobiol. 32:1997;193-201.
42. Guidato S., Bajaj N.P., Miller C.C. Cellular phosphorylation of neurofilament heavy-chain by cyclin-dependent kinase-5 masks the epitope for monoclonal antibody N52. Neurosci. Lett. 217:1996;157-160.
43. Guidato S., Tsai L.H., Woodgett J., Miller C.C. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5. J. Neurochem. 66:1996;1698-1706.
44. Li B.S., Veeranna, Grant P., Pant H.C. Calcium influx and membrane depolarization induce phosphorylation of neurofilament (NF-M) KSP repeats in PC12 cells. Brain Res. Mol. Brain Res. 70:1999;84-91.
45. Li B.S., Veeranna, Gu J., Grant P., Pant H.C. Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. Eur. J. Biochem. 262:1999;211-217.
46. Sharma M., Sharma P., Pant H.C. CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells. J. Neurochem. 73:1999;79-86.
47. Roder H.M., Eden P.A., Ingram V.M. Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Commun. 193:1993;639-647.
48. Veeranna, Amin N.D., Ahn N.G., Jaffe H., Winters C.A., Grant P., Pant H.C. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 18:1998;4008-4021.
49. Hemler M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:1990;365-400.
50. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
51. Trigg D.J., O'Grady K.M., Bhattacharyya T., Reinke M., Toriumi D.M. Peripheral nerve regeneration: comparison of laminin and acidic fibroblast growth factor. Am. J. Otolaryngol. 19:1998;29-32.
52. Paglini G., Pigino G., Kunda P., Morfini G., Maccioni R., Quiroga S., Ferreira A., Careres A. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J. Neurosci. 18:1998;9858-9869.
53. Li B.S., Zhang L., Gu J., Amin N.D., Pant H.C. Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 20:2000;6055-6062.
54. Veeranna, Shetty K.T., Takahashi M., Grant P., Pant H.C. Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain. Brain Res. Mol. Brain Res. 76:2000;229-236.
55. de Waegh S.M., Lee V.M., Brady S.T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68:1992;451-463.
56. Schachner M., Bartsch U. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia. 29:2000;154-165.
57. Quarles R.H. Glycoproteins of myelin sheaths. J. Mol. Neurosci. 8:1997;1-12.
58. Li C., Tropak M.B., Gerlai R., Clapoff S., Abramow-Newerly W., Trapp B., Peterson A., Roder J. Myelination in the absence of myelin-associated glycoprotein. Nature. 369:1994;747-750.
59. Montag D., Giese K.P., Bartsch U., Martini R., Lang Y., Bluthmann H., Karthigasan J., Kirschner D.A., Wintergerst E.S., Nave K.A.et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron. 13:1994;229-246.
60. Bartsch S., Montag D., Schachner M., Bartsch U. Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Brain Res. 762:1997;231-234.
61. Li C., Trapp B., Ludwin S., Peterson A., Roder J. Myelin associated glycoprotein modulates glia-axon contact in vivo. J. Neurosci. Res. 51:1998;210-217.
62. Dashiell S.M., Tanner S.L., Pant H.C., Quarles R.H. Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J. Neurochem. 81:2002;1263-1272.
63. Sharma P., Veeranna, Sharma M., Amin N.D., Sihag R.K., Grant P., Ahn N., Kulkarni A.B., Pant H.C. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277:2002;528-534.
64. Li B.S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A.B., Pant H.C. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21:2002;324-333.
65. Fu A.K., Fu W.Y., Cheung J., Tsim K.W., Ip F.C., Wang J.H., Ip N.Y. Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat. Neurosci. 4:2001;374-381.
66. Si J., Luo Z., Mei L. Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase. J. Biol. Chem. 271:1996;19752-19759.
67. Si J., Mei L. ERK MAP kinase activation is required for acetylcholine receptor inducing activity-induced increase in all five acetylcholine receptor subunit mRNAs as well as synapse-specific expression of acetylcholine receptor epsilon-transgene. Brain Res. Mol. Brain Res. 67:1999;18-27.
68. Tansey M.G., Chu G.C., Merlie J.P. ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway. J. Cell Biol. 134:1996;465-476.
69. Buonanno A., Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11:2001;287-296.
70. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
71. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
72. Dong Z., Brennan A., Liu N., Yarden Y., Lefkowitz G., Mirsky R., Jessen K.R. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron. 15:1995;585-596.
73. Rio C., Rieff H.I., Qi P., Khurana T.S., Corfas G. Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron. 19:1997;39-50.
74. Li Y., Tennekoon G.I., Birnbaum M., Marchionni M.A., Rutkowski J.L. Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival. Mol. Cell. Neurosci. 17:2001;761-767.
75. Li B.S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., Kulkarni A.B., Pant H.C. Cdk5 is involved in neuregulin-dependent activation of PI-3 kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 278:2003;35702-35709.
76. Kesavapany S., Lau K.F., Ackerley S., Banner S.J., Shemilt S.J., Cooper J.D., Leigh P.N., Shaw C.E., McLoughlin D.M., Miller C.C. Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase. J. Neurosci. 23:2003;4975-4983.
77. Westbrook G.L. Glutamate receptor update. Curr. Opin. Neurobiol. 4:1994;337-346.
78. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 34:1995;1219-1237.
79. Ryan T.A., Ziv N.E., Smith S.J. Potentiation of evoked vesicle turnover at individually resolved synaptic boutons. Neuron. 17:1996;125-134.
80. Leonard A.S., Hell J.W. Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272:1997;12107-12115.
81. Mayadevi M., Praseeda M., Kumar K.S., Omkumar R.V. Sequence determinants on the NR2A and NR2B subunits of NMDA receptor responsible for specificity of phosphorylation by CaMKII. Biochim. Biophys. Acta. 1598:2002;40-45.
82. Omkumar R.V., Kiely M.J., Rosenstein A.J., Min K.T., Kennedy M.B. Identification of a phosphorylation site for calcium/calmodulin dependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271:1996;31670-31678.
83. Li B.S., Sun M.K., Zhang L., Takahashi S., Ma W., Vinade L., Kulkarni A.B., Brady R.O., Pant H.C. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12742-12747.
84. Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S.T., Takei K., Matsui H. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22:2002;2590-2597.
85. Veeranna, Grant P., Pant H.C. Expression of p67 (Munc-18), Cdk5, P-NFH and syntaxin during development of the rat cerebellum. Dev. Neurosci. 19:1997;172-183.
86. Fletcher A.I., Shuang R., Giovannucci D.R., Zhang L., Bittner M.A., Stuenkel E.L. Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J. Biol. Chem. 274:1999;4027-4035.
87. Shuang R., Zhang L., Fletcher A., Groblewski G.E., Pevsner J., Stuenkel E.L. Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J. Biol. Chem. 273:1998;4957-4966.
88. Marsh M., McMahon H.T. The structural era of endocytosis. Science. 285:1999;215-220.
89. Wigge P., McMahon H.T. The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci. 21:1998;339-344.
90. Rosales J.L., Nodwell M.J., Johnston R.N., Lee K.Y. Cdk5/p25(nck5a) interaction with synaptic proteins in bovine brain. J. Cell. Biochem. 78:2000;151-159.
91. Floyd S.R., Porro E.B., Slepnev V.I., Ochoa G.C., Tsai L.H., De Camilli P. Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J. Biol. Chem. 276:2001;8104-8110.
92. Tan T.C., Valova V.A., Malladi C.S., Graham M.E., Berven L.A., Jupp O.J., Hansra G., McClure S.J., Sarcevic B., Boadle R.A.et al. Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 5:2003;701-710.
93. Cousin M.A. Synaptic vesicle endocytosis: calcium works overtime in the nerve terminal. Mol. Neurobiol. 22:2000;115-128.
94. Cousin M.A., Robinson P.J. Ca(2+) influx inhibits dynamin and arrests synaptic vesicle endocytosis at the active zone. J. Neurosci. 20:2000;949-957.
95. Cousin M.A., Robinson P.J. The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci. 24:2001;659-665.
96. Cousin M.A., Tan T.C., Robinson P.J. Protein phosphorylation is required for endocytosis in nerve terminals: potential role for the dephosphins dynamin I and synaptojanin, but not AP180 or amphiphysin. J. Neurochem. 76:2001;105-116.
97. Julien J.P. Neurofilament functions in health and disease. Curr. Opin. Neurobiol. 9:1999;554-560.
98. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., Cowburn R.F. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 797:1998;267-277.
99. Brion J.P., Couck A.M. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Am. J. Pathol. 147:1995;1465-1476.
100. Liu W.K., Williams R.T., Hall F.L., Dickson D.W., Yen S.H. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. Am. J. Pathol. 146:1995;228-238.
101. Sengupta A., Wu Q., Grundke-Iqbal I., Iqbal K., Singh T.J. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. Mol. Cell. Biochem. 167:1997;99-105.
102. Honjyo Y., Kawamoto Y., Nakamura S., Nakano S., Akiguchi I. P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy. Acta Neuropathol. (Berl.). 101:2001;190-194.
103. Nakamura S., Kawamoto Y., Nakano S., Akiguchi I., Kimura J. p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease. Acta Neuropathol. (Berl.). 94:1997;153-157.
104. Nakamura S., Kawamoto Y., Nakano S., Akiguchi I., Kimura J. Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy. J. Neuropathol. Exp. Neurol. 57:1998;690-698.
105. Weishaupt J.H., Neusch C., Bahr M. Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res. 312:2003;1-8.
106. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 402:1999;615-622.
107. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature. 405:2000;360-364.
108. Noble W., Olm V., Takata K., Casey E., Mary O., Meyerson J., Gaynor K., LaFrancois J., Wang L., Kondo T.et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron. 38:2003;555-565.
109. Town T., Zolton J., Shaffner R., Schnell B., Crescentini R., Wu Y., Zeng J., DelleDonne A., Obregon D., Tan J.et al. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro. J. Neurosci. Res. 69:2002;362-372.
110. Nath R., Davis M., Probert A.W., Kupina N.C., Ren X., Schielke G.P., Wang K.K. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem. Biophys. Res. Commun. 274:2000;16-21.
111. Taniguchi S., Fujita Y., Hayashi S., Kakita A., Takahashi H., Murayama S., Saido T.C., Hisanaga S., Iwatsubo T., Hasegawa M. Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett. 489:2001;46-50.
112. Vincent I., Bu B., Erickson R.P. Understanding Niemann-Pick type C disease: a fat problem. Curr. Opin. Neurol. 16:2003;155-161.
113. Bu B., Klunemann H., Suzuki K., Li J., Bird T., Jin L.W., Vincent I. Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol. Dis. 11:2002;285-297.
114. Bu B., Li J., Davies P., Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22:2002;6515-6525.
115. Amin N.D., Albers W., Pant H.C. Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J. Neurosci. Res. 67:2002;354-362.
116. Zheng Y.L., Li B.S., Amin N.D., Albers W., Pant H.C. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells. Eur. J. Biochem. 269:2002;4427-4434.
117. Kesavapany S., Lau K.F., McLoughlin D.M., Brownlees J., Ackerley S., Leigh P.N., Shaw C.E., Miller C.C. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur. J. Neurosci. 13:2001;241-247.
118. Kwon Y.T., Gupta A., Zhou Y., Nikolic M., Tsai L.H. Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr. Biol. 10:2000;363-372.
119. Chae T., Kwon Y.T., Bronson R., Dikkes P., Li E., Tsai L.-H. Mice lacking P35, a neuronal-specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron. 18:1997;29-42.
120. Hallows J.L., Chen K., De Pinho R.A., Vincent I. Decreased cyclin-dependent kinase 5 (Cdk5) activity is accompanied by redistribution of Cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in P35 null mice. J. Neurosci. 23:2003;10633-10644.